» Articles » PMID: 17671803

Current Status of Fungal Cell Wall Components in the Immunodiagnostics of Invasive Fungal Infections in Humans: Galactomannan, Mannan and (1-->3)-beta-D-glucan Antigens

Overview
Publisher Springer
Date 2007 Aug 3
PMID 17671803
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Early diagnosis of fungal infections and the implementation of appropriate treatment represent major issues for clinicians, nowadays. Histopathological demonstration of microorganisms in tissue specimens or growth of fungal agents in culture media is still considered the "gold standard", but obtaining such specimens may be difficult. Several groups have investigated serological assays for cell wall elements unique to fungal organisms in serum or other body fluids to improve diagnostics in patients with haematological malignancies or undergoing haematopoietic stem-cell transplantation. In this review we have concentrated on the currently available assays allowing for detection of highly immunogenic components of fungal cell wall: galactomannan, mannan, and also (1-->3)-beta-D-glucan. Rapid serological tests appear to be useful for screening high-risk haematological patients, since they allow for the early diagnosis of invasive fungal infections, including infections with the most common pathogens such as Aspergillus and Candida. Based on current literature, factors increasing the probability of obtaining false-positive or false-negative results detected by each test were also analysed and tabulated.

Citing Articles

Recent Advances in Diagnostic Approaches for Mucormycosis.

Safiia J, Diaz M, Alshaker H, Atallah C, Sakr P, Moshovitis D J Fungi (Basel). 2024; 10(10).

PMID: 39452679 PMC: 11509022. DOI: 10.3390/jof10100727.


[Hemoptysis under immunosuppression].

Sander T, Hohne T, Bansbach J, Muller-Peltzer K, Kalbhenn J Anaesthesiologie. 2022; 72(3):171-174.

PMID: 36583751 PMC: 9802019. DOI: 10.1007/s00101-022-01238-0.


False-positive Elevation of Beta-D-glucan and Aspergillus Galactomannan Levels Due to Mendelson's Syndrome after Rice Aspiration.

Yamamoto T, Oishi K, Suizu J, Murakawa K, Hisamoto Y, Fujii T Intern Med. 2022; 61(19):2935-2939.

PMID: 35314546 PMC: 9593144. DOI: 10.2169/internalmedicine.8805-21.


Diagnostic Performance of (1→3)-β-D-Glucan Alone and in Combination with PCR and Galactomannan in Serum of Pediatric Patients after Allogeneic Hematopoietic Stem Cell Transplantation.

Springer J, Held J, Mengoli C, Schlegel P, Gamon F, Trager J J Fungi (Basel). 2021; 7(3).

PMID: 33810069 PMC: 8004996. DOI: 10.3390/jof7030238.


The putative polysaccharide synthase AfCps1 regulates Aspergillus fumigatus morphogenesis and conidia immune response in mouse bone marrow-derived macrophages.

Wang S, Yuan A, Zeng L, Hou S, Wang M, Li L J Microbiol. 2020; 59(1):64-75.

PMID: 33201436 DOI: 10.1007/s12275-021-0347-x.


References
1.
Usami M, Ohata A, Horiuchi T, Nagasawa K, Wakabayashi T, Tanaka S . Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing. Transfusion. 2002; 42(9):1189-95. DOI: 10.1046/j.1537-2995.2002.00162.x. View

2.
Warnock D . Trends in the epidemiology of invasive fungal infections. Nihon Ishinkin Gakkai Zasshi. 2007; 48(1):1-12. DOI: 10.3314/jjmm.48.1. View

3.
Maertens J, Klont R, Masson C, Theunissen K, Meersseman W, Lagrou K . Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis. 2007; 44(10):1329-36. DOI: 10.1086/514349. View

4.
Kondori N, Edebo L, Mattsby-Baltzer I . Circulating beta (1-3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patients with systemic candidiasis. Clin Diagn Lab Immunol. 2004; 11(2):344-50. PMC: 371202. DOI: 10.1128/cdli.11.2.344-350.2004. View

5.
Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M . Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood. 2001; 97(6):1604-10. DOI: 10.1182/blood.v97.6.1604. View